Osteopenia Active Not Recruiting Phase Trials for Risedronic acid (DB00884)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Active Not RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01406444IGF-1 and Bone Loss in Women With Anorexia NervosaTreatment